The protective mechanism of Yisheng Injection against hepatic ischemia reperfusion injury in mice

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:paokahh
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: Hepatic ischemia/reperfusion injury may cause acute inflammatory, significant organ damage or dysfunction, and remains an important problem for liver transplantation.Our previous in vivo and in vitro studies demonstrated that Yisheng injection (YS), a traditional Chinese medicine, had protective effect on ischemia/reperfusion injury. In this study, we examined whether YS had protective effect for hepatic ischemia/reperfusion injury and explored its protective mechanism.METHODS: Hepatic warm ischemia/reperfusion was induced in mice. YS at different doses (5, 10, 20 mg/kg)was injected intraperitoneally 24 h and 1 h before ischemia and a third dose was injected intravenously just before reperfusion. The hepatocellular injury, oxidative stress,neutrophil recruitment, proinflammatory mediators and adhesion molecules associated with hepatic ischemia/reperfusion injury were assayed by enzyme-linked immunosorbent assay (ELISA), immunohistochemical assay and reverse transcription polymerase chain reaction (RT-PCR).RESULTS: Undergoing 90 min of ischemia and 6 h of reperfusion caused dramatical injuries in mouse livers.Administration of YS at doses of 5, 10 and 20 mg/kg effectively reduced serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and lactate dehydrogenase (LDH), from 3 670±463 U/L, 2 362±323 U/L and 12 752±1 455 U/L in I/R group to 1 172±257 U/L,845±193 U/L and 2 866±427 U/L in YS (20 mg/kg) treated group, respectively (P<0.01). The liver myeloperoxidase (MPO) and malondialdehyde (MDA) contents were decreased from 1.1±0.2 (U/mg protein) and 9.1±0.7 (nmol/mg protein) in I/R group to 0.4±0.1 (U/mg protein) and 5.5±0.9 (nmol/mg protein) in YS (20 mg/kg) treated group, respectively (P<0.01). Moreover, the serum levels of tumor necrosis factor-alpha (TNF-α) were reduced from 55±9.9 (pg/mL) in I/R group to 16±4.2 (pg/mL) (P<0.01).Furthermore, the over-expressions of TNF-α and intercellular adhesion molecule-1 (ICAM-1) were suppressed by YS treatment in a dose-dependent manner.CONCLUSION: YS attenuates hepatic warm ischemia/reperfusion injury by reducing oxidative stress and suppressing the over-expression of proinflammatory mediators and adhesion molecules.
其他文献
目的建立癫痫患儿左乙拉西坦血药浓度的参考区间,并探讨血药浓度相关的影响因素,为临床个体化用药提供参考。方法收集规律服用左乙拉西坦不少于3个月的014岁门诊及住院的332
AIM: rAAV mediated endostatin gene therapy has been examined as a new method for treating cancer. However,a sustained and high protein delivery is required to a
目的:探讨急诊分诊安全管理模式在急诊护理中的应用效果.方法:将我院急诊科救治的116例患者按数字列表法随机分为常规组(分诊常规管理)和试验组(急诊分诊安全管理)各58例,对
目的:探究左氧氟沙星联合头孢他啶治疗尿路感染临床疗效.方法:以我院患者为例,选取2017年5月——2018年5月在我院接受治疗的尿路感染患者,共有患者88人,根据患者意愿将其随机
期刊
期刊
目的 评估各种干预性措施在难治性产后出血中的价值及适用范围.方法 回顾性分析91例难治性产后出血患者病历资料,分析引起产后出血的诱因、产后出血情况以及采用各种干预性措施疗效.结果 91例患者全部成功止血,其中行药物(卡前列素氨丁三醇)止血21例,成功18例(85.71%);行宫腔塞纱28例,成功19例(67.86%);子宫背带式缝合32例,全部成功(100.00%);行子宫动脉结扎20例,成功12
目的 探讨血清纤维连接蛋白、电解质及心肌酶谱检测在新生儿缺氧缺血性脑病(HIE)中的诊疗价值.方法 选取90例HIE患儿作为观察组,临床程度:轻度28例,中度34例,重度28例;同时选取45例正常足月儿作为对照组.测定并比较两组血清纤维连接蛋白、钾、钠、氯、钙以及心肌酶水平.结果 观察组血清纤维连接蛋白水平为(141.23±45.21) g/L,明显低于对照组的(257.51±28.99) g/L
目的:探讨对行微创经皮肾镜取石术治疗肾结石的患者采取护理措施的效果.方法:将我院收治的90例行微创经皮肾镜取石术治疗的肾结石患者分为观察组与对照组,每组45例,对照组给
目的:总结乳腺癌保乳治疗术后局部复发的规律,并分析相关危险因素.方法:217例早期乳腺癌患者均行保乳手术及综合治疗.术后随访1个月~ 6年.结果:217例患者随访期间内随访率为93